AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation

AMP-activated protein kinase (AMPK) is a crucial cellular nutrient and energy sensor that maintains energy homeostasis. AMPK also governs cancer cell invasion and migration by regulating gene expression and activating multiple cellular signaling pathways. ADP-ribosylation factor 6 (Arf6) can be activated via nucleotide exchange by guanine-nucleotide-exchange factors (GEFs), and its activation also regulates tumor invasion and migration. By studying GEF-mediated Arf6 activation, we have elucidated that AMPK functions as a noncanonical GEF for Arf6 in a kinase-independent manner. Moreover, by examining the physiological role of the AMPK-Arf6 axis, we have determined that AMPK activates Arf6 upon glucose starvation and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) treatment. We have further identified the binding motif in the C-terminal regulatory domain of AMPK that is responsible for promoting Arf6 activation and, thus, inducing cell migration and invasion. These findings reveal a noncanonical role of AMPK in which its C-terminal regulatory domain serves as a GEF for Arf6 during glucose deprivation.

Automated summary

AMP-activated protein kinase (AMPK) functions as a noncanonical guanine-nucleotide-exchange factor (GEF) for Arf6 in a kinase-independent manner, therefore playing a crucial role in regulating cancer cell migration and invasion. The activation of Arf6 by AMPK occurs during glucose starvation and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) treatment, involving the C-terminal regulatory domain of AMPK.